Antiretroviral therapy coverage in Guatemala
Guatemala: Antiretroviral therapy coverage was 78.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Guatemala, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Guatemala is 78.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 30.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Guatemala peaked at 78.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Guatemala 57th out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Guatemala, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 11.0% | — |
| 2004 | 11.0% | +0.0% |
| 2005 | 12.0% | +9.1% |
| 2006 | 18.0% | +50.0% |
| 2007 | 28.0% | +55.6% |
| 2008 | 36.0% | +28.6% |
| 2009 | 40.0% | +11.1% |
| 2010 | 44.0% | +10.0% |
| 2011 | 49.0% | +11.4% |
| 2012 | 54.0% | +10.2% |
| 2013 | 59.0% | +9.3% |
| 2014 | 60.0% | +1.7% |
| 2015 | 58.0% | -3.3% |
| 2016 | 58.0% | +0.0% |
| 2017 | 62.0% | +6.9% |
| 2018 | 68.0% | +9.7% |
| 2019 | 71.0% | +4.4% |
| 2020 | 71.0% | +0.0% |
| 2021 | 73.0% | +2.8% |
| 2022 | 76.0% | +4.1% |
| 2023 | 78.0% | +2.6% |
| 2024 | 78.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 15.6% | 0.0% | 40.0% | 10 |
| 2010s | 58.3% | 44.0% | 71.0% | 10 |
| 2020s | 75.2% | 71.0% | 78.0% | 5 |
Countries ranked near Guatemala
- 57 Côte d'Ivoire 78.0% compare
- 59 Nepal 77.0% compare
- 59 United Arab Emirates 77.0% compare
More health data for Guatemala
- Un projection of annual infant deaths, annual growth rate -1.92 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7968 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,202 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,022 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4059 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3488 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Guatemala?
- Antiretroviral therapy coverage in Guatemala was 78.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Guatemala?
- The highest recorded value was 78.0% in 2023.
- What is the lowest antiretroviral therapy coverage recorded in Guatemala?
- The lowest recorded value was 0.0% in 2000.
- How does Guatemala rank for antiretroviral therapy coverage?
- Guatemala ranks 57th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Guatemala?
- Over the last ten years it is up 30.0%. The long-run trend across the full record is volatile.
- Where does this Guatemala data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.